Navigation Links
Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
Date:5/9/2013

ists use a variety of sophisticated and cutting-edge methodologies in the development and validation of tests.  Sequenom CMM is changing the landscape in genetic diagnostics. Visit http://www.sequenomcmm.com for more information on laboratory testing services.

SEQUENOM®, MaterniT21™, MaterniT21™ PLUS, RetnaGene™ and Heredi-T™ are trademarks of Sequenom, Inc.  All other trademarks and service marks are the property of their respective owners.

Forward-Looking Statements
Except for the historical information contained herein, the matters set forth in this press release, including statements regarding the Company's progress in negotiations with payors, indications of steady growth and sustained momentum in 2013 for the Company's diagnostics business,  the Company's expectations to complete the moving of its billing and collections processes in-house and its anticipation of greater control in monitoring payments from payors and improved workflows that will improve collections, maximize reimbursement and improve cash flow and efficiencies, the annualized run rate for the MaterniT21 PLUS test at the end of the first quarter and Sequenom CMM's expectation to exceed 150,000 samples accessioned for all of 2013, the Company's continuing expansion in international markets, Sequenom CMM's expectation for the North Carolina laboratory to begin commercial operations mid-year 2013, the Company's commitment to improving healthcare through revolutionary genetic analysis solutions, and Sequenom CMM's dedication to the development and commercialization of laboratory-developed tests for prenatal and eye conditions and diseases and changing the landscape in genetic diagnostics, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements a
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
2. Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012
3. Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call
4. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
5. Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
6. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
7. Chindex International, Inc. Reports First Quarter 2013 Financial Results
8. BioScrip Reports First Quarter 2013 Financial Results
9. China Biologic Reports Financial Results for the First Quarter of 2013
10. Nephros Reports First Quarter 2013 Financial Results
11. PharmAthene Reports First Quarter 2013 Financial And Operational Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , March 30, 2015 Eli Lilly ... meeting on June 7 to update the investment community ... being held in conjunction with the 75th American Diabetes ... the company,s diabetes business, including a review of the ... be presented during the ADA meeting. The ...
(Date:3/30/2015)... , March 30, 2015 ... Yuval Avni as the company,s new chief executive ... VC, a leading early stage Israeli venture capital firm. ... in general and vascular surgery.        ... today that Sherpa Innoventures is Beta-O2,s newest investor, having ...
(Date:3/30/2015)... , March 30, 2015  The future of ... involve more data analytics; new, more precise methods ... and motion management techniques.  Some 150 researchers from ... last week at a symposium on research funded ... "Researchers are developing, testing, and ...
Breaking Medicine Technology:Lilly Announces Date for Diabetes Investor Meeting 2Beta-O2 Names Dr. Yuval Avni CEO 2Beta-O2 Names Dr. Yuval Avni CEO 3Radiation Oncology Researchers Glimpse the Future of Cancer Care 2Radiation Oncology Researchers Glimpse the Future of Cancer Care 3Radiation Oncology Researchers Glimpse the Future of Cancer Care 4Radiation Oncology Researchers Glimpse the Future of Cancer Care 5Radiation Oncology Researchers Glimpse the Future of Cancer Care 6
(Date:3/30/2015)... 2015 The partners of Urgent Care ... opening of the Bella Diosa Laser Med Spa, offering ... in laser med spa treatments. , February marked the ... the partnership bridges the medical services provided by Urgent ... by Bella Diosa for both women and men. , ...
(Date:3/30/2015)... 2015 “We are pleased to announce ... on May 30 in Los Angeles,” said Mark Wolper, ... pilots nominated from a nationwide call for nominations. ... Flight Mid-Atlantic, Richard Durden with LightHawk and Stephen Purello ... the award recipients will receive a $15,000 contribution from ...
(Date:3/30/2015)... 30, 2015 A key protein previously ... plays an important role in the response to viral ... the Icahn School of Medicine at Mount Sinai published ... long been associated with inflammation, part of the body’s ... cells home in to attack invaders like bacteria and ...
(Date:3/30/2015)... This report studies the global tumor ... to 2019. , Based on the type of ... into four major segments, namely radio-frequency, microwave, cryoablation ... and laser ablation) segments. Moreover, based on type ... classified into three segments, namely, interventional radiology, surgery ...
(Date:3/30/2015)... 30, 2015 Recently, 10 Best Water ... Awards, with the top three winners being Fiji water, Tibet ... company’s website, along with other informative information about water. ... spring water, mineral water and sparkling water are among the ... the top exotic water brands highlighted on the site. ...
Breaking Medicine News(10 mins):Health News:Yonkers Celebrates the Grand Opening of Bella Diosa 2Health News:2015 Endeavor Awards Recipients Announced 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 2Health News:The Global Tumor Ablation Market is Poised to Reach the Value of $462.0 Million in 2019 - MarketsandMarkets Released Recently 3Health News:Best Exotic Water Brands Acclaimed by 10 Best Water 2
... , FRIDAY, Sept. 9 (HealthDay News) -- College ... power over time, but smaller improvements in speed and ... physical capabilities of 289 Division III college players throughout ... senior year, the players, body mass increased an average ...
... News) -- More than one-half of all adverse drug ... according to a new study. In addition, prior ... which include drug overdoses and internal bleeding associated with ... are life-threatening, said the Swedish researchers. This widespread problem, ...
... , FRIDAY, Sept. 9 (HealthDay News) -- Fundraising methods such ... the ability to make a donation on state income tax ... and prevention programs in the United States, a new study ... enable taxpayers to check a box on their income tax ...
... Coukell, a pharmacist and director of medical programs at ... Health Education Labor and Pensions Committee about the need ... U.S. drug supply. Nearly 80 percent ... Increasingly, Americans rely on pharmaceuticals that are produced ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, Sept. ... anxious about caring for their infant. But sometimes that concern ... go wrong. Experts call that condition postpartum obsessive compulsive ... prevent their fears from coming true, such as endlessly washing ...
... (HealthDay News) -- People are at much higher risk ... according to a new study. Canadian researchers found ... is likely to develop COPD, which they called "one of ... emphysema and chronic bronchitis, and the overall risk for developing ...
Cached Medicine News:Health News:Over Half of Adverse Drug Reactions in Hospitals Are Preventable: Study 2Health News:When Protecting Baby Becomes an Obsession 2Health News:When Protecting Baby Becomes an Obsession 3Health News:Risk for COPD Higher Than Thought: Study 2
... Water, The Simplicity personal water system is ... use bottled water. In addition to the ... bottled water, your laboratory applications may be ... absorbed from containers and cause water quality ...
... 12 L/min of Type I ultrapure water, ... Super-Q Plus System is designed to provide ... been pretreated by reverse osmosis, distillation or ... water quality which exceeds Type I ASTM/CAP/NCCLS ...
... Compact System Produces Type I Water Directly from ... designed for scientists who need 5 to 15 ... not have easy access to acceptable quality pretreated ... 0.6 L/min of ultrapure (Type I) water on ...
... mechanism for speed, stability and durability. ... display modes, multiple units of measure, ... auto print, and GLP/GMP/ISO output including ... clock. Touch-key calibration with external weights ...
Medicine Products: